3M raises €1B in Eurobonds as stock trades below fair value
What's the deal? 3M has raised roughly €1 billion through fixed-rate Eurobonds maturing in 2028 and 2031. The debt gives the industrial manufacturer fresh long-term funding and lands as its shares trade below several analyst targets.
Why now? The raise follows a rough stretch for the stock. 3M's one-month share price return is down 9.68%, though the 90-day return is up 4.26% and the one-year total shareholder return sits at 6.43%.
What's the endgame? The company is betting on innovation and efficiency to drive earnings. New product launches are up 70% year on year, targeting 215 for the year, while five-year innovation sales rose 9% and are expected to top 15% growth.
Operational gains — better on-time delivery, higher equipment effectiveness, lower quality costs, and supply chain consolidation — are lifting operating margins, with further automation expected to compound the benefits.
By the numbers: 3M's most-followed valuation narrative pegs fair value at about $181.85, roughly 9.3% above the last close of $164.97, marking the stock as undervalued. The €1 billion debt sits within that wider valuation context.
What could go wrong? That fair-value case rests on assumptions holding. The narrative hinges on PFAS litigation staying contained and on productivity gains not stalling if macro conditions or execution stumble.
The signal: At roughly $1.16 billion, the raise ranks in the 92nd percentile among post-IPO debt rounds tied to Belgium, all-time. For a company navigating a share wobble and litigation overhang, tapping the European bond market for long-dated funding signals a move to lock in capital and reinforce the balance sheet while equity sentiment cools.
Read more: simplywall.st
Image credit: liewcf
